The Loblaw Companies Limited conglomerate announced plans to merge with pharmacy and grocery store chain Shoppers Drug Mart Corporation in a deal worth nearly $12 billion, according to a press release. Reports say the buyout will allow Loblaw to step into the market of small-urban stores, while Shoppers Drug Mart will continue to operate independently under its own name. The plans remain subject to shareholder and regulatory approval. The deal has not come without resistance, however, as some have speculated what the merger would mean for consumers in Canada, say reports.
Featured News
Digital-Asset Treasury Companies Push Boundaries of Corporate Finance
Nov 7, 2025 by
CPI
European Commission Considering Delaying Full Implementation of AI Act by a Year
Nov 7, 2025 by
CPI
Judge Withholds Approval of Google–Epic Games Antitrust Settlement Pending Review
Nov 6, 2025 by
CPI
Bank of England Vows to Issue Stablecoin Regs ‘Just as Quickly as the U.S.’
Nov 6, 2025 by
CPI
No Federal Bailout for AI, Says White House Tech Chief
Nov 6, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Costs of Consolidation
Oct 26, 2025 by
CPI
Does Merger Enforcement Protect Consumers from the Long-Term Costs of Consolidation?
Oct 26, 2025 by
Diana L. Moss
“Praying for Inflation”: How Market Concentration Facilitates Inflationary Pressures
Oct 26, 2025 by
John Kwoka & Muhammad Shabanpour
Unpacking the Remedy: The Hidden Costs of Merger Remedies and the Economist’s Role in Getting Them Right
Oct 26, 2025 by
Sam R. Carless, Mary Coleman & David Weiskopf
Why Industry Consolidation Causes More Concern Than It Should
Oct 26, 2025 by
Michael Noel